1. No Pharmacokinetic Interaction Between the Hepatitis C Virus Inhibitors Elbasvir/Grazoprevir and Famotidine or Pantoprazole. Issue 5 (17th June 2017) Authors: Feng, H‐P; Vaddady, P; Guo, Z; Liu, F; Panebianco, D; Levine, V; Caro, L; Butterton, JR; Iwamoto, M; Yeh, WW Journal: Clinical and translational science Issue: Volume 10:Issue 5(2017) Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Single‐Dose and Multiple‐Dose Pharmacokinetics of Vaniprevir in Healthy Men. Issue 6 (10th August 2017) Authors: Caro, L; de Hoon, J; Depré, M; Cilissen, C; Miller, J; Gao, W; Panebianco, D; Guo, Z; Troemel, SL; Anderson, MS; Uemura, N; Butterton, J; Wagner, J; Wright, DH Journal: Clinical and translational science Issue: Volume 10:Issue 6(2017) Page Start: 480 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗